Holdings Information

Bibliographic Record Display

• Title:Individualized diabetes management : a guide for primary care / Anthony Barnett, Jenny Grice.
  
•    
• Author/Creator:Barnett, A. H. (Anthony H.), 1951- author.
  
• Other Contributors/Collections:Grice, Jenny, author.
  
• Published/Created:Boca Raton, FL : CRC Press, Taylor & Francis Group [2016]
  

• Holdings

  Holdings Record Display

  • Location:WOODWARD LIBRARY stacksWhere is this?
    
  • Call Number: WK810 .B261i 2016
    
  • Number of Items:1
    
  • Status:Available
    

   
• Library of Congress Subjects:Diabetes--Treatment--Great Britain.
  
• Medical Subjects: Diabetes Mellitus, Type 2--epidemiology.
  Diabetes Mellitus, Type 2--therapy.
  Precision Medicine.
  Primary Health Care.
  United Kingdom.
  
• Description:xiv, 115 pages ; 20 cm
  
• Notes:Includes bibliographical references and index.
  
• ISBN:9781498762090 paperback ; alkaline paper
  1498762093 paperback ; alkaline paper
  
• Contents:Machine generated contents note: 1. Type 2 diabetes: epidemiology, complications and costs
  Epidemiology
  Diabetes complications
  Costs
  References
  2. Challenges to glycaemic control
  Type 2 diabetes is a progressive disease
  Adherence to management plans
  Clinical inertia
  Provider barriers
  Patient barriers
  System barriers
  Overcoming clinical inertia
  References
  3. Barriers to adherence and their solutions
  Which patients are most at risk of non-adherence?
  Age-related morbidities
  Lifestyle challenges
  Change in situation
  Loss or lack of motivation
  Depression
  Ethnicity
  Poor perception and knowledge of disease
  Problems with therapy
  Complexity of dosing regimen
  Fear of injections
  Safety and tolerability
  Lack of knowledge
  How to question patients about non-adherence
  Tailor adherence solution to non-adherence problem
  Conclusions
  References
  4. Advantages and disadvantages of new therapies
  Older therapies
  Metformin
  Modified-release metformin
  Sulphonylureas
  Meglitinides
  Thiazolidinediones (glitazones)
  Alpha-glucosidase inhibitors
  Newer therapies
  Incretin-based therapies
  DPP-4 inhibitors
  GLP-1 receptor agonists
  SGLT-2 inhibitors
  Combination therapy with newer agents
  References
  5. New insulin developments
  Basal insulins
  Biosimilar insulins
  Insulin degludec
  Glargine U300
  Rapid-acting insulin analogues
  Ultra-rapid-acting insulin analogues
  Inhaled insulin
  Conclusions
  References
  6. Personalised management
  Factors to consider in personalised diabetes management
  Lifestyle management
  Pre-diabetes
  Diagnosed type 2 diabetes
  Pharmacotherapy
  Early and intensive treatment with initial combination therapy
  Advantages of a personalised approach
  References
  7. Organisation of diabetes care
  Role of the primary care team in multi-professional care
  Aims of integrated care
  Personalised care planning
  Preparing for a care planning discussion
  References.